Please assess the completion status of the following clinical trial:

Trial Title: Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* LVEF \< 40% (by any imaging modality: echocardiography/SPECT/LV angiography)~* A history of Q-wave MI with a residual akinetic and nonviable scar (as evidenced by low-dose dobutamine stress echocardiogram and/or or thallium redistribution nuclear study for viability and/or an electrocardiogram)~* Patients scheduled for surgical revascularization within few days (\< 2 weeks) of the initial screening~Exclusion Criteria:~* Age \>75 by time of infusion~* Cardiogenic shock~* Severe co-morbidities (e.g., renal failure, liver failure)~* Mini-CABG procedures~* Pregnant/nursing women or women of child-bearing potential~* Inability to provide informed consent~* Diabetic Hgb A1c \> 8.5%~* Patients with a history of hepatitis B, hepatitis C, and HIV

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Treatment group (Type: EXPERIMENTAL): Patients in this arm received intracoronary expanded autologous c-kit positive cardiac stem cells.
- Control group (Type: NO_INTERVENTION): Patients in this arm did not receive any intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).